MaxCyte, Inc. (MXCT)

MaxCyte Revenue

MaxCyte had revenue of $8.51M in the quarter ending June 30, 2025, a decrease of -18.43%. This brings the company's revenue in the last twelve months to $35.75M, down -21.31% year-over-year. In the year 2024, MaxCyte had annual revenue of $38.63M, down -6.44%.

• Revenue (ttm): $35.75M
• Revenue Growth: -21.31%
• P/S Ratio: 4.58
• Revenue / Employee: $313,632
• Employees: 114
• Market Cap: 165.24M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	38.63M	-2.66M	-6.44%
Dec 31, 2023	41.29M	-2.97M	-6.72%
Dec 31, 2022	44.26M	10.37M	30.59%
Dec 31, 2021	33.89M	7.73M	29.52%
Dec 31, 2020	26.17M	4.55M	21.04%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.